Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Prasanna Rajagopalan

18PUBLICATIONS

5CO-AUTHORS

Haematological tumoursBiologically active moleculesProteins and peptidesCheminformatics and quantitative structure-activity relationshipsCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Oct 08, 2022

Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations.

Mohammad Abohassan, Mesfer Alshahrani, Mohammad Y Alshahrani

|Jul 23, 2022

Identification of second generation benzylidene chromanone analogues as novel, potent DHODH inhibitors in acute myeloid leukemia cells.

Mohammad Abohassan, Mesfer Al Shahrani, Prasanna Rajagopalan

|Apr 22, 2022

GC/MS characterization and computational kinome-wide screening of pomegranate fruit extract identifies key phytochemicals interacting to CDK kinases implicated in acute myeloid leukemia cells.

Mohammad Abohassan, Mesfer Al Shahrani, Irfan Ahmad

|Mar 24, 2022

Computational analysis and in vitro evaluation of TMF 104, for its antioxidant, antimicrobial, and anticancer efficacies.

Ahmed Saif, Mesfer Al Shahrani, Mohammed Alshehri

|Mar 05, 2022

Glucose and oleic acid mediate cellular alterations in GLP-1-induced insulin-positive differentiating UCBMSCs.

Harish C Chandramoorthy, Ayed A Dera, Ahmed Al-Hakami

|Nov 02, 2021

High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma.

Mesfer Al Shahrani, Mohammad Abohassan, Mohammad Y Alshahrani

Pageof 3

Frequent Collaborators

10 joint publications

Ayed Dera

1 joint publications

Harish C Chandramoorthy

1 joint publications

Mishari Alshyarba

1 joint publications

Kameswaran Ravichandran

1 joint publications

Ahmed Saif

Frequent Collaborators

10 joint publications

Ayed Dera

1 joint publications

Harish C Chandramoorthy

1 joint publications

Mishari Alshyarba

1 joint publications

Kameswaran Ravichandran

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on : Feb 09, 2021

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on : Jan 07, 2019

See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on : Feb 09, 2021

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on : Jan 07, 2019

See more related videos